Literature DB >> 22010574

MicroRNAs, an active and versatile group in cancers.

Jeffrey Liu1, Min Zheng, Ya-Ling Tang, Xin-Hua Liang, Qin Yang.   

Abstract

microRNAs (miRNAs) are a class of non-coding RNAs that function as endogenous triggers of the RNA interference pathway. Studies have shown that thousands of human protein-coding genes are regulated by miRNAs, indicating that miRNAs are master regulators of many important biological processes, such as cancer development. miRNAs frequently have deregulated expression in many types of human cancers, and play critical roles in tumorigenesis, which functions either as tumor suppressors or as oncogenes. Recent studies have shown that miRNAs are highly related with cancer progression, including initiating, growth, apoptosis, invasion, and metastasis. Furthermore, miRNAs are shown to be responsible for the cancer-related inflammation, anti-cancer drug resistance, and regulation of cancer stem cells. Therefore, miRNAs have generated great interest as a novel strategy in cancer diagnosis and therapy. Here we review the versatile roles of miRNAs in cancers and their potential applications for diagnosis, prognosis, and treatment as biomarkers.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22010574      PMCID: PMC3469973          DOI: 10.4248/IJOS11063

Source DB:  PubMed          Journal:  Int J Oral Sci        ISSN: 1674-2818            Impact factor:   6.344


  28 in total

Review 1.  MicroRNA-21 is a novel promising target in cancer radiation therapy.

Authors:  Jia Liu; Hongcheng Zhu; Xi Yang; Yangyang Ge; Chi Zhang; Qin Qin; Jing Lu; Liangliang Zhan; Hongyan Cheng; Xinchen Sun
Journal:  Tumour Biol       Date:  2014-01-21

2.  Prognostic role of microRNA-100 in various carcinomas: evidence from six studies.

Authors:  Jie Chen; Biqiang Zheng; Chunmeng Wang; Yong Chen; Chunyan Du; Guangfa Zhao; Ye Zhou; Yingqiang Shi
Journal:  Tumour Biol       Date:  2013-11-21

3.  MicroRNA 224 Regulates Ion Transporter Expression in Ameloblasts To Coordinate Enamel Mineralization.

Authors:  Yi Fan; Yachuan Zhou; Xuedong Zhou; Feifei Sun; Bo Gao; Mian Wan; Xin Zhou; Jianxun Sun; Xin Xu; Lei Cheng; Janet Crane; Liwei Zheng
Journal:  Mol Cell Biol       Date:  2015-06-08       Impact factor: 4.272

4.  Metformin inhibits cell growth by upregulating microRNA-26a in renal cancer cells.

Authors:  Feng-Qiang Yang; Ji-Jiao Wang; Jia-Sheng Yan; Jian-Hua Huang; Wei Li; Jian-Ping Che; Guang-Chun Wang; Min Liu; Jun-Hua Zheng
Journal:  Int J Clin Exp Med       Date:  2014-10-15

Review 5.  Decoy activity through microRNAs: the therapeutic implications.

Authors:  Maria Ines Almeida; Rui Manuel Reis; George Adrian Calin
Journal:  Expert Opin Biol Ther       Date:  2012-06-01       Impact factor: 4.388

6.  MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.

Authors:  Jing Liu; Kai-Hua Lu; Zhi-Li Liu; Ming Sun; Wei De; Zhao-Xia Wang
Journal:  BMC Cancer       Date:  2012-11-14       Impact factor: 4.430

7.  Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines.

Authors:  Aliaksandr Druz; Yu-Chi Chen; Rajarshi Guha; Michael Betenbaugh; Scott E Martin; Joseph Shiloach
Journal:  RNA Biol       Date:  2013-01-25       Impact factor: 4.652

8.  MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma.

Authors:  Na Wang; Chao-Qi Zhang; Jia-Huan He; Xiao-Fei Duan; Yuan-Yuan Wang; Xiang Ji; Wen-Qiao Zang; Min Li; Yun-Yun Ma; Tao Wang; Guo-Qiang Zhao
Journal:  Dig Dis Sci       Date:  2013-03-17       Impact factor: 3.199

Review 9.  miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.

Authors:  Volker Baumann; Johannes Winkler
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

Review 10.  Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity.

Authors:  Luqing Zhao; Ann M Bode; Ya Cao; Zigang Dong
Journal:  Carcinogenesis       Date:  2012-07-12       Impact factor: 4.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.